Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Sep 2026.
- Largest single sale: $1.0M (1,215 shares) of Regeneron Pharmaceuticals on Sep 2, 2026. Filing
- Last sale before this period: Nov 1, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | EVP Commercial | Feb 12, 2018 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 3, 2026, Regeneron Pharmaceuticals: sold 1,131 shares for $970K, under a disclosed plan. 1 filing: 1
- Sep 2, 2026, Regeneron Pharmaceuticals: sold 1,215 shares for $1.0M, under a disclosed plan. 1 filing: 1
- Dec 9, 2025, Regeneron Pharmaceuticals: 1,021 shares withheld by the company for taxes. 1 filing: 1
- Dec 8, 2025, Regeneron Pharmaceuticals: 1,336 shares withheld by the company for taxes. 1 filing: 1
- Dec 5, 2025, Regeneron Pharmaceuticals: 2,476 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.